MAR 26, 2022 3:00 AM PDT

Classifying Biomarkers for Neuropsychiatric Lupus

WRITTEN BY: Katie Kokolus

Lupus is an autoimmune disease characterized by one’s immune system targeting and harming itself, and it can impact several tissues and organs, including the joints, skin, kidneys, brain, heart, lungs, and blood vessels. Lupus is associated with widespread inflammation around the affected tissues leading to severe damage.  

According to the CDC, systemic lupus erythematosus (SLE) is the most common and serious type of lupus. Patients with SLE experience symptoms including fatigue, rash, fever, and joint pain. While some patients experience infrequent flares of SLE symptoms, others exhibit symptoms more often. There is no cure for SLE, but clinical management and lifestyle interventions can control symptoms.  

When SLE impacts tissues related to the nervous system such as the brain, spinal cord, or nerves, it is classified as neuropsychiatric SLE (NPSLE). About half of SLE patients have NPSLE, associated with neurology-related issues, including headaches, seizures, depression, and demyelination (damage to the protective tissue covering nerves). There are no definitive biomarkers to identify NPSLE. To address this limitation, a team of researchers examined the cerebrospinal fluid (CSF), the liquid around the brain and spinal cord, from NPSLE patients. They recently published their findings in Arthritis & Rheumatology.  

After screening for over 1,000 proteins from NPSLE patients, the researchers identified four potential biomarkers, Lipocalin-2, M-CSF, IgM, and complement C3, which appeared in a large percentage of patients with NPSLE.  Notably, the study obtained CSF samples from two diverse cohorts of patients.  The “Halifax” cohort included 24 predominantly Caucasian female patients and the 17 patients in the “Hong Kong” cohort were Chinese females.  The researchers also collected samples from patients without NPSLE at both locations.  Patients from the “Control” group were diagnosed with other neuroinflammatory diseases such as multiple sclerosis, Parkinson’s disease, and fibromyalgia or were being evaluated for NPSLE-associated symptoms like dizziness or seizures. 

The authors acknowledged limitations to this study, including the small sample size.  Indeed, a large-scale study examining the biomarkers identified here could validate the potential of developing a diagnostic strategy.  An accurate and efficient method for identifying and diagnosing NPSLE would significantly improve clinical management of the disease.

 

Sources: Arth Rheum, Neurology

About the Author
PhD
PhD in Tumor Immunology. I am interested in developing novel strategies to improve the efficacy of immunotherapies used to extend cancer survivorship.
You May Also Like
APR 20, 2022
Microbiology
Rapid AST: A key weapon in the fight against AMR
APR 20, 2022
Rapid AST: A key weapon in the fight against AMR
Despite the dire, well-documented risks of antimicrobial resistance (AMR), which threatens to kill 10 million people a y ...
MAY 16, 2022
Cell & Molecular Biology
How To Ensure You Are Using High Quality Laboratory Consumables That Produce Consistent Results
MAY 16, 2022
How To Ensure You Are Using High Quality Laboratory Consumables That Produce Consistent Results
There are many important considerations when choosing your laboratory consumables. How do you know that the plastic labw ...
JUN 06, 2022
Clinical & Molecular DX
Researchers Confirm the Impact of Gut Viruses on Inflammatory Bowel Disease
JUN 06, 2022
Researchers Confirm the Impact of Gut Viruses on Inflammatory Bowel Disease
The gut microbiome refers to the collection of microorganisms that reside within the gut. The gut microbiome is known to ...
MAY 19, 2022
Cardiology
Death from Heart Attacks More Common in US than Other High-Income Countries
MAY 19, 2022
Death from Heart Attacks More Common in US than Other High-Income Countries
The US has a high rate of heart attack mortality compared to other high-income countries.
JUN 01, 2022
Genetics & Genomics
Newly ID'ed Disease Explains Some Liver & Kidney Dysfunction
JUN 01, 2022
Newly ID'ed Disease Explains Some Liver & Kidney Dysfunction
Some people with unexplained liver and kidney issues may now have an answer. Researchers have found that mutations in a ...
JUL 04, 2022
Cancer
Caesar Rodney: A Founding Father Suffering from Facial Cancer
JUL 04, 2022
Caesar Rodney: A Founding Father Suffering from Facial Cancer
Today the United States celebrates Independence Day, the quintessential American holiday commemorating the day the Found ...
Loading Comments...